Evommune Stock

www.evommune.com/Healthcare / BioTech & PharmaFounded: 2020

Evommune, founded in 2020, is a biotechnology company that focuses on developing treatments for highly prevalent inflammatory diseases. Taking a tissue-based approach to insights and accelerating the development of transformative medicines for inflammatory diseases, Evommune seeks to create strategies to treat inflammatory disorders by developing treatments that address symptoms while also halting disease progression. Evommune is headquartered in Palo Alto, California.

Register To Buy and Sell Shares

For more details on financing and valuation for Evommune, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Evommune’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Evommune.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.

Evommune investors also invested in these private companies

Andera Partners
Pivotal bioVenture Partners
LSP BioVentures
Amplitude Venture Capital
Arix Bioscience
EQT Life Sciences


Management Team

Luis Peña
Co-Founder, Chief Executive Officer & President
Kyle Carver
Chief Financial Officer
Jeegar Patel Ph.D
Chief Scientific Officer
Hans Hofland Ph.D
Co-Founder & Senior Vice President of Research
Gregory Moss
Chief Corporate Strategy & Legal Officer
Eugene Bauer
Chief Medical Officer

Board Members

Ashish Khanna Ph.D
Pivotal bioVenture Partners
Felice Verduyn-Van Weegen
EQT Life Sciences

Evommune’s stock FAQs


Can you buy Evommune’s stock?

Evommune is not publicly traded on NYSE or NASDAQ in the U.S. To buy Evommune’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Can you sell Evommune’s stock?

Yes, you can sell stock of a private company like Evommune. Forge can help you sell your Evommune stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.

What is Evommune’s stock price?

Evommune is a privately held company and therefore does not have a public stock price. However, you may access Evommune’s private market stock price with Forge Data.

What is Evommune’s stock ticker symbol?

Evommune does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.
Updated on: Jun 18, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.